2 months ago
CYTK
AnalystsGena WangGena Wang's Stock Forecasts
AnalystsGena Wang
Sectors:
Industries:
Analyst Ranking
Top 29%
#1481 out of 5192 analysts
Average Return
+1.12%
Win Rate
43%75 out of 173
Risk vs Reward
Poor
Good
Gena Wang's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Beam Therapeutics IncBEAM | +315.20% | $23.02 | $95.58 | 2020-03-02 - 2021-03-01 | Strong Buy |
Moderna IncMRNA | +260.41% | $59.10 | $213.00 | 2020-06-08 - 2021-06-08 | Strong Buy |
4d Molecular Therapeutics IncFDMT | +203.57% | $3.08 | $9.35 | 2025-05-09 - 2026-02-13 | Strong Buy |
Biocryst Pharmaceuticals IncBCRX | +170.38% | $3.95 | $10.68 | 2020-05-05 - 2021-05-05 | Strong Buy |
Cellectis SaCLLS | +164.54% | $1.41 | $3.73 | 2025-05-13 - 2026-02-13 | Strong Buy |
Gena Wang Analyst Color
Get additional color on Gena Wang's coverage of popular stocks
3 months ago
BCRX
4 months ago
ALNY
4 months ago
BMRN
4 months ago
CLLS
2 years ago
VIR
2 years ago
SLDB
2 years ago
RGNX
2 years ago
SRPT
2 years ago
VRTX
2 years ago
LEGN
3 years ago
VRTX
3 years ago
LEGN
3 years ago
LEGN
Gena Wang's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Legend Biotech CorpLEGN | 8 | Strong Buy | $80.00 | +355.06% | Maintains | 12 days ago |
Cytokinetics IncCYTK | 6 | Strong Buy | $87.00 | +31.30% | Assumes | 20 days ago |
Ultragenyx Pharmaceutical IncRARE | 7 | Strong Buy | $50.00 | +143.66% | Maintains | 3 months ago |
4d Molecular Therapeutics IncFDMT | 3 | Strong Buy | $33.00 | +252.94% | Maintains | 3 months ago |
Moderna IncMRNA | 10 | Hold | $25.00 | -40.80% | Maintains | 3 months ago |
Intellia Therapeutics IncNTLA | 9 | Strong Buy | $14.00 | +17.94% | Maintains | 3 months ago |
Sangamo Therapeutics IncSGMO | 5 | Hold | $1.00 | +158.40% | Downgrades | 3 months ago |
Ptc Therapeutics IncPTCT | 17 | Hold | $68.00 | -2.09% | Maintains | 3 months ago |
Sarepta Therapeutics IncSRPT | 16 | Hold | $20.00 | +12.42% | Maintains | 3 months ago |
Vertex Pharmaceuticals IncVRTX | 17 | Hold | $414.00 | -15.76% | Maintains | 3 months ago |
Solid Biosciences IncSLDB | 8 | Strong Buy | $9.00 | +45.40% | Maintains | 3 months ago |
Biocryst Pharmaceuticals IncBCRX | 11 | Hold | $9.00 | +33.14% | Maintains | 3 months ago |
Alnylam Pharmaceuticals IncALNY | 8 | Strong Buy | $527.00 | +67.62% | Maintains | 4 months ago |
Ionis Pharmaceuticals IncIONS | 11 | Strong Buy | $95.00 | +17.87% | Maintains | 4 months ago |
Biomarin Pharmaceutical IncBMRN | 6 | Strong Buy | $80.00 | +33.62% | Maintains | 4 months ago |
Cellectis SaCLLS | 4 | Strong Buy | $8.00 | +114.48% | Maintains | 4 months ago |
Kodiak Sciences IncKOD | 10 | Hold | $17.00 | -22.97% | Upgrades | 5 months ago |
Regenxbio IncRGNX | 7 | Strong Buy | $37.00 | +363.08% | Maintains | 6 months ago |
Avidity Biosciences IncRNA | 4 | Strong Buy | $62.00 | -14.92% | Maintains | 6 months ago |
Crispr Therapeutics AgCRSP | 16 | Hold | $56.00 | +5.52% | Maintains | 6 months ago |
Beam Therapeutics IncBEAM | 10 | Hold | $21.00 | -24.79% | Maintains | 6 months ago |
Bluebird Bio IncBLUE | 10 | Strong Buy | $8.00 | +60.97% | Maintains | a year ago |
Vir Biotechnology IncVIR | 5 | Strong Buy | $31.00 | +314.99% | Maintains | a year ago |
Editas Medicine IncEDIT | 9 | Hold | $3.00 | N/A | Maintains | a year ago |
Mirati Therapeutics IncMRTX | 6 | Strong Buy | $71.00 | N/A | Maintains | 3 years ago |
Seagen IncSGEN | 3 | Hold | $228.00 | N/A | Maintains | 3 years ago |
Zymeworks IncZYME | 1 | Hold | $9.00 | N/A | Maintains | 3 years ago |
Arcturus Therapeutics Holdings IncARCT | 5 | Hold | $25.00 | N/A | Upgrades | 3 years ago |
Orchard Therapeutics PLCORTX | 2 | Strong Buy | $40.00 | N/A | Maintains | 4 years ago |
Meiragtx Holdings PLCMGTX | 1 | Strong Buy | $18.00 | N/A | Maintains | 4 years ago |
Tectonic Therapeutic IncTECX | 3 | Strong Buy | $48.00 | N/A | Maintains | 4 years ago |
Decibel Therapeutics IncDBTX | 2 | Strong Buy | $7.00 | N/A | Maintains | 4 years ago |
Sigilon Therapeutics IncSGTX | 1 | Strong Buy | $91.00 | N/A | Maintains | 4 years ago |
Logicbio Therapeutics IncLOGC2 | 1 | Strong Buy | $8.00 | N/A | Maintains | 4 years ago |
Axonics IncAXNX | 1 | Strong Buy | $79.00 | N/A | Maintains | 5 years ago |
Aceragen IncACGN | 1 | Hold | $2.00 | N/A | Downgrades | 5 years ago |
Eidos Therapeutics IncEIDX | 1 | Strong Sell | $45.00 | N/A | Downgrades | 6 years ago |
Tesaro IncTSRO | 1 | Hold | $75.00 | N/A | Downgrades | 7 years ago |
Puma Biotechnology IncPBYI | 5 | Strong Sell | $29.00 | N/A | Downgrades | 7 years ago |
Spark Therapeutics IncONCE | 4 | Strong Buy | $77.00 | N/A | Maintains | 8 years ago |
Avexis IncAVXS | 3 | Hold | N/A | N/A | Downgrades | 8 years ago |
Juno Therapeutics IncJUNO | 2 | Hold | N/A | N/A | Downgrades | 8 years ago |
Cascadian Therapeutics IncCASC | 1 | Strong Sell | $4.00 | N/A | Initiates Coverage On | 8 years ago |
Abeona Therapeutics IncABEO | 1 | Strong Buy | $275.00 | N/A | Initiates Coverage On | 9 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.